Article

Prevent musculoskeletal pain by addressing psychosocial factors

Persons in consistently good musculoskeletal health-those who do not report musculoskeletal pain-often demonstrate low levels of psychosocial problems, such as depression, anxiety, sleep disturbance, traumatic experiences, and somatization.

Persons in consistently good musculoskeletal health-those who do not report musculoskeletal pain-often demonstrate low levels of psychosocial problems, such as depression, anxiety, sleep disturbance, traumatic experiences, and somatization. Promoting low levels of illness behavior and psychological distress and high-quality sleep appears to be effective in improving musculoskeletal health and preventing chronic musculoskeletal pain conditions.

Jones and colleagues conducted a 4-year longitudinal study of a population-based group of patients recruited from general practices in England. Patients were questioned about musculoskeletal pain and related psychosocial factors at 15 months and 4 years.

Patients reporting the least amount of musculoskeletal discomfort had the lowest psychological distress, depression, and anxiety scores. They slept well, seldom were ill, had few somatic complaints, and had experienced no significant trauma in the previous 6 months. Good quality sleep, low illness behavior, low psychological distress, and absence of traumatic life events were independent predictors of good musculoskeletal health. The relationship was strong: 46% of persons with all 4 of these findings reported being pain-free, compared with only 5% of patients who had none of these qualities.

The authors noted that further research is needed to establish the effects of musculoskeletal health–promoting interventions on pain conditions.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.